Blake Schutter Theil Wealth Advisors LLC Invests $272,000 in Healthpeak Properties, Inc. (NYSE:DOC)

Blake Schutter Theil Wealth Advisors LLC purchased a new stake in Healthpeak Properties, Inc. (NYSE:DOC) during the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm purchased 11,893 shares of the real estate investment trust’s stock, valued at approximately $272,000.

Several other hedge funds have also added to or reduced their stakes in the company. abrdn plc bought a new position in Healthpeak Properties in the third quarter valued at about $62,670,000. Douglas Lane & Associates LLC bought a new position in Healthpeak Properties in the third quarter valued at about $33,947,000. Foresight Group Ltd Liability Partnership bought a new position in Healthpeak Properties in the third quarter valued at about $33,212,000. Asset Management One Co. Ltd. bought a new position in Healthpeak Properties in the third quarter valued at about $29,934,000. Finally, Raymond James & Associates bought a new position in Healthpeak Properties in the third quarter valued at about $25,711,000. Institutional investors own 93.57% of the company’s stock.

Healthpeak Properties Stock Up 1.0 %

NYSE:DOC opened at $22.56 on Friday. The company has a debt-to-equity ratio of 0.93, a quick ratio of 1.31 and a current ratio of 1.31. The company has a market cap of $15.78 billion, a PE ratio of 48.00, a PEG ratio of 2.45 and a beta of 1.13. Healthpeak Properties, Inc. has a 52-week low of $15.44 and a 52-week high of $23.26. The stock has a 50-day simple moving average of $22.31 and a 200 day simple moving average of $20.91.

Healthpeak Properties (NYSE:DOC) last posted its quarterly earnings data on Thursday, October 24th. The real estate investment trust reported $0.12 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.44 by ($0.32). The firm had revenue of $700.40 million for the quarter, compared to the consensus estimate of $682.51 million. Healthpeak Properties had a return on equity of 3.53% and a net margin of 12.10%. The firm’s quarterly revenue was up 25.9% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.45 earnings per share. On average, sell-side analysts expect that Healthpeak Properties, Inc. will post 1.8 EPS for the current fiscal year.

Healthpeak Properties Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Monday, November 4th will be paid a $0.30 dividend. The ex-dividend date of this dividend is Monday, November 4th. This represents a $1.20 dividend on an annualized basis and a yield of 5.32%. Healthpeak Properties’s dividend payout ratio is 255.32%.

Analyst Upgrades and Downgrades

Several equities analysts recently issued reports on the company. Wells Fargo & Company reiterated an “equal weight” rating and issued a $23.00 price target (up previously from $22.00) on shares of Healthpeak Properties in a report on Tuesday, October 1st. Evercore ISI increased their target price on Healthpeak Properties from $25.00 to $26.00 and gave the company an “outperform” rating in a research note on Monday, September 16th. Wedbush increased their target price on Healthpeak Properties from $22.00 to $25.00 and gave the company an “outperform” rating in a research note on Monday, July 29th. Royal Bank of Canada increased their target price on Healthpeak Properties from $25.00 to $26.00 and gave the company an “outperform” rating in a research note on Monday. Finally, Deutsche Bank Aktiengesellschaft raised Healthpeak Properties from a “hold” rating to a “buy” rating and increased their target price for the company from $20.00 to $28.00 in a research note on Monday, October 21st. One research analyst has rated the stock with a sell rating, five have issued a hold rating, ten have issued a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, Healthpeak Properties has a consensus rating of “Moderate Buy” and a consensus target price of $22.86.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.